Hilliard Lyons Downgrades Abbvie (ABBV) to Neutral
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $250.09 +0.85%
Rating Summary:
27 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
27 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
Hilliard Lyons downgraded Abbvie (NYSE: ABBV) from Long-Term Buy to Neutral.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $37.80 yesterday.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $37.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades On Holding AG (ONON) to Market Perform
- H.C. Wainwright Downgrades Heron Therapeutics (HRTX) to Neutral
- UBS Downgrades Carl Zeiss Meditec AG (AFXG:GR) to Sell
Create E-mail Alert Related Categories
DowngradesRelated Entities
Hilliard LyonsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
